All Insights Infographic Optimize Resources in Real Time for Improved Efficiency and Agility
Optimize Resources in Real Time for Improved Efficiency and Agility
Optimize Resources in Real Time for Improved Efficiency and Agility
Axtria’s Commercial Excellence Summit roundtable brought together pharmaceutical industry leaders to brainstorm ways to meet the current challenges of commercializing precision drugs and personalized medicines.

Many commercial teams believe that stitching together multiple point solutions is the best path to omnichannel excellence—offering perceived control, flexibility, and cost efficiency. But disconnected systems create data silos, inconsistent experiences, and hidden operational costs that undermine true commercial impact.
Omnichannel success requires more than just technology. It demands a strategic approach that unifies insights, execution, and measurement. In this infographic, we break down the five key components of a high-impact omnichannel strategy and reveal how Axtria’s AI-powered field force platform drives true omnichannel excellence to transform commercial performance.
FAQs
Dynamic Resource Allocation is the continuous mid cycle reallocation of budget, field effort, and channel mix. It helps pharma companies redirect resources from low performing areas to high ROI opportunities while campaigns are still running.
Axtria MarketingIQ™ powers DRA by ingesting live data such as TRx trends, CRM activity, HCP engagement, and rep feedback. It then simulates reallocation scenarios, applies business guardrails, and pushes updates directly to CRM, media platforms, and field planning systems.
Pharma companies can see up to 20% higher HCP engagement, 40% faster insights-to-actions, up to 2-3x faster response to market changes, and up to $4mn incremental revenue in 6 months.
MMx is designed for long term planning and is mostly refreshed quarterly or biannually. DRA operates between those refreshes, reallocating resources in weeks instead of months. MMx sets the strategy, while DRA ensures execution stays aligned with real time market shifts.
With DRA, allocation can be refreshed every 2–4 weeks, compared to quarterly or longer with MMx. The cadence depends on therapy area dynamics, data availability, and business needs.
